CGRP was reported to increase the force of contractility by stimulating the sympathetic nervous system, which was further supported by Gennari et al. (1990) when patients with congestive heart failure (CHF) demonstrated improved cardiac contractility after receiving β-CGRP infusion for 24 h (12.5 ug/h). Here, CALCA is linked to congestive heart failure.